Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-03-06Clinical Trial Update: Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency
A clinical trial evaluating how cholesterol levels affect long-term patency of coronary artery bypass grafts has been withdrawn; the study i…
-
CLINICAL_TRIALS withdrawal · 2024-07-25Clinical Trial Update: Cardiovascular Risk Reduction in Epilepsy [NA]
A UCLA-sponsored clinical trial on cardiovascular risk reduction in epilepsy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-05-10Clinical Trial Update: Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia [Phase 3]
Phase 3 trial comparing NK-104-CR and Livalo IR in primary hyperlipidemia or mixed dyslipidemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-05-10Clinical Trial Update: Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia [Phase 3]
Phase 3 trial NK-104-CR for primary hyperlipidemia or mixed dyslipidemia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-11Clinical Trial Update: Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood [Phase 2, Phase 3]
A Phase 2/3 clinical trial investigating a palm-oil-derived supplement and Chinese red yeast rice for cholesterol lowering was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-12-02Clinical Trial Update: Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects [Phase 3]
Pfizer has withdrawn the Phase 3 trial evaluating bococizumab for lipid lowering in Asian subjects with primary hyperlipidemia or mixed dysl…
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: Study of the Effects of Blackcurrant Extract and Omega-3 Fats on the Health of the Heart and Blood Vessels
A clinical trial evaluating blackcurrant extract and omega-3 fats for cardiovascular health was withdrawn before completion.
-
CLINICAL_TRIALS withdrawal · 2016-09-27Clinical Trial Update: Genetic Influence on Statin Pharmacodynamics
A clinical trial investigating genetic influence on statin pharmacodynamics was withdrawn from the registry.
-
CLINICAL_TRIALS withdrawal · 2015-09-10Clinical Trial Update: Genomic Dissection of a QTL Affecting the Lipid Profile
A clinical trial update indicates that the study examining a quantitative trait locus affecting lipid metabolism has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-22Clinical Trial Update: A Pilot Study on the Effect of Vitamin D Treatment in Patients With Statin-Associated Myalgia [Phase 1]
A pilot Phase 1 trial evaluating vitamin D for relief of statin-associated myalgia in patients with hyperlipidemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-24Clinical Trial Update: Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors [Phase 4]
Phase 4 trial evaluating ezetimibe/simvastatin and MK0524A in mixed hyperlipidemia with multiple risk factors was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-22Clinical Trial Update: Garlic in Hyperlipidemia Caused by HAART [Phase 2]
This update indicates a Phase 2 trial evaluating garlic for HAART-induced hyperlipidemia in people with HIV has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-19Clinical Trial Update: Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART [NA]
This clinical trial evaluated a mixed exercise regime combined with L-Carnitine supplementation in HIV patients on HAART. The study has been…